Therapeutic potential of antifungal plant and insect defensins

Drug Discovery Today

Volumn 12, Issue 21-22, 2007, Pages 966-971

  Thevissen, Karin ^a   Kristensen, Hans Henrik ^b   Thomma, Bart P H J ^c   Cammue, Bruno P A ^a   François, Isabelle E J A ^a  

^a Centre of Microbial and Plant Genetics   (Belgium)

^b NOVOZYMES A S   (Denmark)

^c WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DEFENSIN; FLUCONAZOLE; HELIOMYCIN; ITRACONAZOLE; MICONAZOLE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ASPERGILLUS FLAVUS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CELL CYCLE REGULATION; DRUG ACTIVITY; DRUG BINDING SITE; DRUG EFFICACY; DRUG PROTEIN BINDING; FUNGICIDAL ACTIVITY; FUSARIUM SOLANI; IN VIVO STUDY; MUTATIONAL ANALYSIS; NONHUMAN; PLANT DEFENSE; POSTTRANSCRIPTIONAL GENE SILENCING; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; TRANSCRIPTION INITIATION; VIRUS EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; ANTIFUNGAL AGENTS; DEFENSINS; HUMANS; INSECT PROTEINS; MOLECULAR SEQUENCE DATA; MYCOSES; PLANT PROTEINS; RECOMBINANT PROTEINS;

EID: 35748984637     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2007.07.016     Document Type: Review

References (63)

1. Garbino J., et al. Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital. Medicine (Baltimore) 81 (2002) 425-433
2. Hobson R.P. The global epidemiology of invasive Candida infections-is the tide turning?. J. Hosp. Infect. 55 (2003) 159-168
3. Pfaller, et al. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance. J. Clin. Microbiol. 44 (2006) 760-763
4. Marr K.A. Invasive Candida infections; the changing epidemiology. Oncology 18 (2004) 9-14
5. Vonberg R.P., and Gastmeier P. Nosocomial aspergillosis in outbreak settings. J. Hosp. Infect. 63 (2006) 246-254
6. François I.E.J.A., et al. Currently used antimycotics: spectrum, mode of action and resistance occurrence. Curr. Drug Targets 6 (2005) 895-907
7. Landon C., et al. Lead optimization of antifungal peptides with 3D NMR structures analysis. Protein Sci. 13 (2004) 703-713
8. Thomma B.P.H.J., et al. Plant Defensins. Planta 216 (2002) 193-202
9. Thomma B.P.H.J., et al. Mode of action of plant defensins suggests therapeutic potential. Curr. Drug Targets Infect. Disord. 3 (2003) 1-8
10. Lay F.T., and Anderson M.A. Defensins-components of the innate immune system in plants. Curr. Protein Pept. Sci. 6 (2005) 85-101
11. Chen G.H., et al. Cloning and characterization of a plant defensin VaD1 from azuki bean. J. Agric. Food Chem. 53 (2005) 982-988
12. Andres E., and Dimarcg L. Cationic antimicrobial peptides: from innate immunity study to drug development. Med. Mal. Infect. 37 (2007) 194-199
13. Terras F.R., et al. Analysis of two novel classes of plant antifungal proteins from radish (Raphanus sativus L.) seeds. J. Biol. Chem. 267 (1992) 15301-15309
14. Osborn R.W., et al. Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae. FEBS Lett. 368 (1995) 257-262
15. Lamberty L., et al. Insect immunity. Isolation from the lepidopteran Heliothis virescens of a novel insect defensin with potent antifungal activity. J. Biol. Chem. 274 (1999) 9320-9326
16. Onyewu C., et al. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata and Candida krusei. Antimicrob. Agents Chemother. 47 (2003) 956-964
17. Saito K., et al. Presence of glucosylceramide in yeast and its relation to alkali tolerance of yeast. Appl. Microbiol. Biotechnol. 71 (2006) 515-521
18. Thevissen K., et al. Specific, high affinity binding sites for an antifungal plant defensin on Neurospora crassa hyphae and microsomal membranes. J. Biol. Chem. 272 (1997) 32176-32181
19. Thevissen K., et al. Permeabilization of fungal membranes by plant defensins inhibits fungal growth. Appl. Environ. Microbiol. 65 (1999) 5451-5458
20. Thevissen K., et al. Specific binding sites for an antifungal plant defensin from Dahlia (Dahlia merckii) on fungal cells are required for antifungal activity. Mol. Plant Microbe Interact. 13 (2000) 54-61
21. Thevissen K., et al. A gene encoding a sphingolipid biosynthesis enzyme determines the sensitivity of Saccharomyces cerevisiae to an antifungal plant defensin from dahlia (Dahlia merckii). Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 9531-9536
22. Thevissen K., et al. DmAMP1, an antifungal plant defensin from dahlia (Dahlia merckii), interacts with sphingolipids from Saccharomyces cerevisiae. FEMS Microbiol. Lett. 226 (2003) 169-173
23. Thevissen K., et al. Defensins from insects and plants interact with fungal glucosylceramides. J. Biol. Chem. 279 (2004) 3900-3905
24. Aerts, A. et al. (2007) The antifungal activity of RsAFP2, a plant defensin from Raphanus sativus, involves the induction of reactive oxygen species in Candida albicans. J. Mol. Microbiol. Biotechnol. DOI:10.1159/000104753
25. Ames B.N., et al. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7915-7922
26. Therade-Matharan S., et al. Reactive oxygen species production by mitochondria in endothelial cells exposed to reoxygenation after hypoxia and glucose depletion is mediated by ceramide. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 (2005) 1756-1762
27. Madeo F., et al. A yeast mutant showing diagnostic markers of early and late apoptosis. J. Cell. Biol. 139 (1997) 729-734
28. Almeida M.S., et al. Characterization of two novel defense peptides from pea (Pisum sativum) seeds. Arch. Biochem. Biophys. 378 (2000) 278-286
29. Lobo D.S., et al. Antifungal Pisum sativum defensin 1 interacts with Neurospora crassa cyclin F related to the cell cycle. Biochemistry 46 (2007) 987-996
30. Thevissen K., et al. Currently used antimycotics: spectrum, mode of action and resistance occurrence. Curr. Drug Targets 6 (2005) 895-907
31. Luberto C., et al. Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of Cryptococcus neoformans. Genes Dev. 15 (2001) 201-212
32. Rittershaus P.C., et al. Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans. J. Clin. Invest. 116 (2006) 1651-1659
33. Hannun Y.A., and Luberto C. Ceramide in the eukaryotic stress response. Trends Cell. Biol. 10 (2000) 73-80
34. Thevissen K., et al. Ceramide involvement in apoptosis and apoptotic diseases. Mini Rev. Med. Chem. 6 (2006) 699-709
35. Stock S.D., et al. Syringomycin E inhibition of Saccharomyces cerevisiae: requirement for biosynthesis of sphingolipids with very-long-chain fatty acids and mannose- and phosphoinositol-containing head groups. Antimicrob. Agents Chemother. 44 (2000) 1174-1180
36. Peng C., et al. The hydrophobic surface of PaAMP from pokeweed seeds is essential to its interaction with fungal membrane lipids and the antifungal activity. FEBS Lett. 579 (2005) 2445-2450
37. Nimrichter L., et al. A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages. Microbes Infect. 6 (2004) 657-665
38. Ramamoorthy V., et al. Two mitogen-activated protein kinase signalling cascades mediate basal resistance to antifungal plant defensins in Fusarium graminearum. Cell Microbiol. 9 (2007) 1491-1506
39. Lengeler K.B., et al. Signal transduction cascades regulating fungal development and virulence. Microbiol. Mol. Biol. Rev. 64 (2000) 746-785
40. De Samblanx G.W., et al. Mutational analysis of a plant defensin from radish (Raphanus sativus L.) reveals two adjacent sites important for antifungal activity. J. Biol. Chem. 272 (1997) 1171-1179
41. Pervieux I., et al. A spruce defensin showing strong antifungal activity and increased transcript accumulation after wounding and jasmonate treatments. Physiol. Plant Pathol. 64 (2004) 331-341
42. Da-Hui L., et al. Bacterial expression of a Trichosanthes kirilowii defensin (TDEF1) and its antifungal activity on Fusarium oxysporum. Appl. Microbiol. Biotechnol. 74 (2007) 146-151
43. Bessette P.H., et al. Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13703-13708
44. Yuan Y., et al. Functional expression of a Drosophila antifungal peptide in Escherichia coli. Protein Expr. Purif. 52 (2007) 457-462
45. Michaut L., et al. Determination of the disulfide array of the first inducible antifungal peptide from insects:drosomycin from Drosophila melanogaster. FEBS Lett. 395 (1996) 6-10
46. Landon C., et al. Solution structure of drosomycin, the first inducible antifungal protein from insects. Protein Sci. 6 (1997) 1878-1884
47. Cabral K.M., et al. Production of the active antifungal Pisum sativum defensin 1 (Psd1) in Pichia pastoris: overcoming the inefficiency of the STE13 protease. Protein Expr. Purif. 31 (2003) 115-122
48. Yoder W.T., and Lehmbeck J. Heterologous expression and protein secretion in filamentous fungi. In: Tkacz J.S., and Lange L. (Eds). Advances in Fungal Biotechnology for Industry, Agriculture, and Medicine (2004), Kluwer Academic/Plenum Publishers 201-219
49. Mygind H., et al. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437 (2006) 975-980
50. Schnorr, K. et al (2003) Novozymes. Novel plectasin polypeptide having antimicrobial activity, useful for (for example) killing or inhibiting microbial cell growth, for use as a medicament and as antimicrobial therapeutic or prophylactic agent. International patent application WO2003044049-A1
51. Hjort C.M. Production of food additives using filamentous fungi. In: Heller K.J. (Ed). Genetically Engineered Food (2003), Wiley-VCH Press 86-99
52. François I.E.J.A., et al. Transgenic expression in Arabidopsis of a polyprotein construct leading to production of two different antimicrobial proteins. Plant Phys. 128 (2002) 1346-1358
53. François I.E.J.A., et al. Processing in Arabidopsis thaliana of a heterologous polyprotein resulting in differential targeting of the individual plant defensins. Plant Sci. 166 (2004) 113-121
54. Sels J., et al. Use of a PTGS-MAR expression system for efficient in planta production of bioactive Arabidopsis thaliana plant defensins. Transgenic Res. (2006) 10.1007/s11248-006-9057-8
55. Aerts A.M., et al. Arabidopsis thaliana plants expressing human beta-defensin-2 are more resistant to fungal attack: functional homology between plant and human defensins. Plant Cell Rep. (2007) 10.1007/s00299-007-0329-4
56. Butaye K.M., et al. Stable high-level expression in Arabidopsis thaliana using gene silencing mutants and matrix attachment regions. Plant J. 39 (2004) 440-449
57. Saitoh H., et al. Production of antimicrobial defensin in Nicotiana benthamiana with a potato virus × vector. Mol. Plant-Microbe Interact. 14 (2001) 111-115
58. Schmidt A. Animal models of aspergillosis-also useful for vaccination strategies?. Mycoses 45 (2002) 38-40
59. Clemons K.V., and Stevens D.A. Animal models of Aspergillus infection in preclinical trials, diagnostics and pharmacodynamics: what can we learn from them?. Med. Mycol. 44 (2006) 119-126
60. Andres E., and Dimarcq J.L. Cationic anti-microbial peptides: from innate immunity study to drug development. Rev. Med. Intern. 25 (2004) 629-635
61. van Baarlen P., et al. Disease induction by human microbial pathogens in plant model systems: potential, problems and prospects. Drug Discov. Today 12 (2007) 167-173
62. van Baarlen P., et al. Molecular mechanisms of pathogenicity: how do pathogenic microorganisms develop cross-kingdom host jumps?. FEMS Microbiol. Rev. 31 (2007) 239-277
63. Rex J.H., and Pfaller M.A. Has antifungal susceptibility testing come of age?. Clin. Infect. Dis. 35 (2002) 982-989